Progenitor Therapeutics Overview

  • Founded
  • 2010
  • Status
  • Out of Business
  • Latest Deal Type
  • Out of Business

Progenitor Therapeutics General Information


Provider of regenerative medicine designed to regenerate specific tissues of the human body. The company's medicine focuses on helping the body cure itself, rather than treating the symptoms of diseases, enabling patients to regenerate specific tissues of their body in response to injury, disease or aging.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Therapeutic Devices
Primary Office
  • Stevenage Bioscience Catalyst
  • Gunnels Wood Road
  • Stevenage SG1 2FX
  • England, United Kingdom
+44 020 0000 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Progenitor Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Out of Business 01-Oct-2017 00.000 Completed Out of Business
2. Seed Round 11-Mar-2013 00.000 00.000 Completed Generating Revenue
1. Seed Round 01-Apr-2011 Completed Generating Revenue
To view Progenitor Therapeutics’s complete valuation and funding history, request access »